StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Raised to $334 at Oppenheimer Amid Aducanuma News
October 22, 2019 11:53 AM
Oppenheimer analyst Jay Olson raised the price target on Biogen (NASDAQ: BIIB) to $334.00 (from $280.00) while maintaining a Outperform ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Biogen (BIIB) PT Raised to $305 at Canaccord Genuity
October 23, 2019 5:14 AM
Biogen (BIIB) PT Raised to $297 at BMO Capital
October 23, 2019 4:44 AM
Biogen (BIIB) PT Raised to $310 at Jefferies
October 22, 2019 1:45 PM
